Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 709
Selected: 0
NCT IDTitle
NCT01424670Safety and Efficacy Trial of Delamanid for 6 Months in Participants With Multidrug-resistant Tuberculosis
NCT01646827An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia
NCT01942161A Short Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia
NCT04782258A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)
NCT01182415High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma or Central Nervous System (CNS) Lymphoma
NCT01457885Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
NCT02020278An Extension Follow-up Trial to Evaluate the Long-term Safety of Children and Adolescent Participants With Euvolemic or Hypervolemic Hyponatremia
NCT01349335Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With Ascites
NCT02697045Effects of Aripiprazole (LAI) on Phychosocial/Cognitive Functioning, pt Reported AcceptabilityofTreatment in Sch
NCT05741528An Extension Study to a Clinical Study That Will Continue to Evaluate the Effectiveness and Safety of SEP-363856 in People With Schizophrenia That Switch to SEP-363856 From Their From Their Current Antipsychotic Medication
NCT01141400The Effect of Patient Cost-Sharing on Antidepressant and Adjunctive Therapy Use
NCT02722863Samsca Post Marketing Surveillance Study
NCT02069119A Trial to Determine the Safety, Pharmacokinetics, and Efficacy of OPC-108459 Administered as a Single Intravenous Dose to Patients With Paroxysmal or Persistent Atrial Fibrillation (AF)
NCT04786730A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine Capsules in Pediatric Subjects With Attention-deficit Hyperactivity Disorder
NCT00401271Safety, Efficacy and Pharmacokinetics of OPC-67683 in Patients With Pulmonary Tuberculosis
NCT03850509Efficacy and Safety of Oral OPS-2071 in Participants With Crohn's Disease Showing Symptoms of Active Inflammation
NCT00479336A Dose-defining Study of OPC-41061 in Treatment of Hepatic Edema
NCT00545675Abilify in Bipolar Disorder for 24 Weeks Treatment Effectiveness
NCT02237417Impact of Aripiprazole Once Monthly Medications on Changes in Brain Structure and Metabolism
NCT03198078Trial to Evaluate the Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With Schizophrenia
NCT01131351Safety and Pharmacokinetics (PK) in Multidrug-Resistant (MDR) Refractive Tuberculosis
NCT02282085Treatment Study Comparing Aripiprazole Once Monthly With Standard of Care Medication in Outpatients With Schizophrenia
NCT00948090PK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma Patients
NCT01795547Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia
NCT07209761A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis
NCT00102063Aripiprazole in Adolescents With Schizophrenia
NCT07087327A Long-term Trial of EB-1020 in Pediatric Patients With ADHD
NCT01084551Study of SPM 962 in Patients With Restless Legs Syndrome (RLS)
NCT02402595Drug Interaction Study Between AVP-923 and Itraconazole and Between AVP-786 and Itraconazole in Healthy Adult Subejcts
NCT02442765Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
NCT04838639Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of NO-13065 in Healthy and Obese Adult Subjects
NCT05926375Effect of HINEX Jelly on Nutritional Status in People With Possible Sarcopenia or Sarcopenia
NCT05221502Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB
NCT03961529Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic Dermatitis
NCT02964273Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autosomal Dominant Polycystic Kidney Disease)
NCT04313153Trial Evaluating the Efficacy and Safety of Oral Vadadustat Once Daily (QD) and Three Times Weekly (TIW) for the Maintenance Treatment of Anemia in Hemodialysis Subjects Converting From Erythropoiesis-Stimulating Agents (ESAs)
NCT03418675Brexpiprazole in Borderline Personality Disorder
NCT07058233Oral Nutritional Supplementation and Weight Changes During Therapy in Malnourished Patients With Resistant Tuberculosis: A Clinical Trial
NCT02534038Safety, Tolerability and Efficacy of AVP-786 for the Treatment of Disinhibition
NCT03487198The Safety and Efficacy of Brexpiprazole as Adjunctive Therapy in the Treatment of Major Depressive Disorder
NCT00589927Triple Versus Dual Antiplatelet Therapy After ABT578-Eluting Stent
NCT01670279Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder
NCT01456897A Long-term Trial of OPC-34712 in Patients With Schizophrenia
NCT01397786Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
NCT02250170Safety and Biomarker of OPB-111077 in Subjects With Advanced Solid Tumor
NCT01727713Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
NCT01668797Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
NCT00657176An Open-Label Phase-1 Study of OPB-31121 in Patients With Advanced Solid Tumors
NCT01395017Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer
NCT01981811Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder